Assessment of treatment patterns of nonmuscle invasive bladder cancer patients in privately insured patients.

e16012Background: 75–85% of bladder cancer patients present with non-muscle invasive disease (NMIBC). While transurethral resection of bladder tumors (TURBT) is the initial standard treatment for v...